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colitis; leukocyte; angiogenesis; vascular endothelial growth factor receptor; adhesion VASCULAR ENDOTHELIAL GROWTH FACTOR-A (VEGF-A) is a potent endothelial mitogen that acts as a driving force behind angiogenic responses. Our group and others have shown that VEGF-A is involved in pathological angiogenic activity during inflammatory bowel disease (IBD), rheumatoid arthritis, and diabetic macular degeneration (4 -6) . Recent data indicate that this pathological angiogenic response results in proinflammatory signaling, suggesting that it likely plays a role in the establishment of chronic inflammation during IBD (3) . Specifically, the VEGF 164 isoform, the predominant splice variant of the VEGF-A gene, has been shown, and confirmed herein, to be responsible for the pathological effects of VEGF in chronic inflammatory settings (28) . Importantly, our recent findings indicate that VEGF 164 provides a crucial link between angiogenesis and inflammation during IBD, leading to the establishment of chronic disease (4) .
VEGF 164 -dependent inflammatory activation involves the upregulation of cellular adhesion molecules (CAMs), such as intracellular adhesion molecule-1 (ICAM-1) and vascular cellular adhesion molecule-1 (VCAM-1) (13, 18) . This can result in the accumulation of various inflammatory cells (e.g., neutrophils, monocyte/macrophages, and T cells) within the colonic tissue, thereby exacerbating chronic inflammatory pathways. We have shown that pathological levels, similar to those seen in IBD, of VEGF 164 (i.e., Ͼ50 ng/ml) stimulate neutrophil adhesion similar to that of tumor necrosis factor-␣ (TNF-␣) under physiological flow and that genetic deficiency or inhibition of the ␤2-integrin (Itgb2) prevents VEGF 164 -dependent recruitment of neutrophils and T cells (13) . However, it is not known which of the ␣-integrin (Itga) pairs are involved in governing leukocyte adhesion to VEGF-A-activated colon endothelium.
Leukocyte/endothelial cell interactions are critically important for the recruitment of inflammatory cells into affected tissue. The Itgb2 family is known to be the major leukocyte ligands for endothelial CAMs (12, 14, 20) . This family consists of four members, ItgaL/Itgb2 (lymphocyte function-associated antigen-1), ItgaM/Itgb2 (macrophage antigen-1), ItgaX/Itgb2, and ItgaD/Itgb2. Inflammatory cytokine induction of ICAM-1 and VCAM-1 expression on activated endothelial cells increases cell surface location of these proteins, which cluster around caveolae, creating areas of increased leukocyte/endothelial cell interaction, leading to rolling and firm adhesion (19, 25, 27 ). These findings demonstrate the complexity of CAMs with their integrin ligands, underscoring the need to determine the specific adhesion molecule mechanisms by which VEGF 164 regulates leukocyte recruitment. However, no studies have yet determined which leukocyte Itgas are responsible for the specific recruitment of different leukocyte types in response to VEGF 164 activation of colonic endothelial cells.
Here we hypothesize that VEGF 164 /VEGF receptor (VEGFR) signaling results in differential Itga-dependent recruitment of leukocytes. We show that VEGF 164 -dependent neutrophil recruitment is mainly dependent on ItgaM expression, whereas VEGF 164 -dependent T cell adhesion involves both ItgaL and ItgaM expression. Additionally, we find that specific inhibition of VEGFR2 results in decreased neutrophil adhesion, whereas both VEGFR1 and VEGFR2 activations contribute to VEGF-A-dependent T cell adhesion.
MATERIALS AND METHODS
Animals. Mice used in these experiments were bred and housed in the Louisiana State University Health Sciences Center-Shreveport for Assessment and Accreditation of Laboratory Animal Care, an internationally accredited animal resource facility. All experimental protocols were approved by the institutional animal care and use committee. ItgaL Ϫ/Ϫ and ItgaM Ϫ/Ϫ mice were bred in house. C57BL/6J mice were obtained from Jackson Laboratories.
Cell culture. Immortalized murine colonic endothelial cells (MCEC) isolated from Immortomouse mice were cultured in EMEM containing D-valine supplemented with FBS, L-glutamine, nonessential amino acids, and antibiotic-antimycotic as previously reported (13) . For experiments, the cells were deimmortalized in DMEM media for 2 days at 37°C as previously described. Cells were plated in 35-mm culture dishes and grown to confluence for parallel-plate flow chamber experiments.
Neutrophil and T cell isolation. Bone marrow-derived neutrophils were isolated from the femurs of 10 -12-wk-old C57BL/6J, ItgaL Ϫ/Ϫ , and ItgaM Ϫ/Ϫ mice. Briefly, the femurs were dissected from the mice and placed on ice in Petri dishes containing RPMI. The marrow was then removed by passing 2.5 ml of RPMI through both ends of the bones into 50-ml conical tubes and filtering through 100-m cell strainers into another 50-ml conical tube. Seven-milliliter aliquots were then layered 1:1 onto Histopaque 1077 density medium in 15-ml tubes and spun at 4°C at 700 g for 30 min with no break. The pellet was resuspended in 5 ml of AKC lysis buffer and spun at 1,300 revolution/min for 5 min, then rinsed twice in sterile HBSS. During this time, 10.7 l of DMSO was added to two tubes of CellTracker Green and vortexed. Pellets were then resuspended in 8 ml of sterile HBSS containing 16 l of CellTracker Green solution and rocked on ice for 40 min. Cells were then rinsed twice with sterile HBSS and resuspended at a concentration of 200,000 cells per milliliter for the parallel-plate flow chamber.
T cells were isolated from the spleens of C57BL/6J, ItgaL Ϫ/Ϫ , and ItgaM Ϫ/Ϫ mice as previously described (13) . Briefly, spleenectomy was performed on the mice, and the spleens were placed in PBS containing 2% FBS on ice. The spleens were then ground and filtered twice through 70-m cell filters. CD3 ϩ T cells were then purified and labeled with CellTracker Green in the same manner as the neutrophils, for the flow chamber assay.
Flow cytometry analysis. Flow cytometry analysis was performed as we have previously reported (13, 24) . Briefly, isolated T cells and neutrophils were blocked with Fc block (anti-mouse CD16/32) for 15 min on ice. T cells were stained for two-color flow cytometry using CD4 and one of the following integrins: ItgaL (CD11a), Itgb2 (CD18), Itgb1 (CD29), Itga4 (CD49d), ItgaM (CD11b), ItgaX (CD11c), and appropriate isotype controls (commercial antibodies from eBioscience or BD Biosciences). Specimens were gated on CD4 staining and subsequently measured for various integrin staining intensity. Likewise, integrin expression of isolated neutrophils was determined the same way except without CD4 gating. All samples were analyzed with a fluorescence-activated cell sorting Calibur flow cytometer (Becton Dickinson) using Cell Quest software (Becton Dickinson) by the Research Core Facility at the Louisiana State University Health Sciences Center. Ten thousand events were collected per replicate with four replicates per experiment. All cell staining analyses were performed in duplicate.
Parallel-plate flow chamber assay. Parallel-plate flow chamber assays were performed with the cells described above. Thirty-fivemillimeter dishes of MCEC cells were placed on a heated stage at 37°C, and neutrophil and T cell suspensions were placed on a 37°C hot plate with a stir bar at 200 revolution/min. Leukocytes were perfused through the Glycotech chamber with a syringe pump at 300 l/min, at the physiological sheer rate of 1.5 dynes/cm 2 , as previously described (13) . Digital videos were taken at ϫ20 magnification on a Nikon Eclipse TE-2000S epifluorescent scope using a FITC cube for 1 min and 30 s at six different points on each plate. The videos were analyzed for the number of firmly adherent cells and number of slow rolling cells using Simple PCI software (C-Imaging Systems).
VEGFR inhibitors. Blocking VEGFR1 and R2 receptor inhibitor antibodies were obtained from Abcam and added to the cells 1 h before VEGF 164 treatment. Cells were incubated for 1 h at 37°C with either the VEGFR1 (10 g/ml) or R2 (0.8 g/ml) neutralizing antibody before treatment with 50 ng/ml VEGF 164 for 4 h. Experiments were then done as described in Parallel-plate flow chamber assay.
Statistical analysis. Statistical analyses were done using Students t-test or ANOVA with a Bonferroni's posttest among all groups and are presented as means Ϯ SE. P values Ͻ0.05, Ͻ0.01, or Ͻ0.0001 are significant as indicated on figures. All experiments were replicated at least twice, and experimental N values are reported in the figure legends. 164 -stimulated colonic endothelium. ItgaL/Itgb2 and ItgaM/Itgb2 are known be involved in neutrophil and T cell recruitment in postcapillary venules. Table 1 reports cell surface adhesion molecule expression for Itgb2, ItgaL, ItgaM, ItgaX, Itgb1, and Itga4 on isolated T cells and neutrophils. We have previously shown that the loss of CD18 (Itgb2) results in decreased recruitment of leukocytes in response to VEGF-A stimulation of mouse colonic microvascular endothelium; however, the role of the specific Itgas in this process has not been examined. Here we used ItgaL Ϫ/Ϫ and ItgaM Ϫ/Ϫ neutrophils to examine the specific importance of these two integrins in response to VEGF 164 -stimulated leukocyte recruitment. Stimulation of colonic endothelial cells with TNF-␣ (10 ng/ml) increased firm adhesion of neutrophils as shown in Fig. 1A . Neutrophils lacking ItgaL showed a significant decrease in TNF-␣ mediated firm adhesion with ItgaM Ϫ/Ϫ neutrophils also showing an equivalent decrement in adhesion to that of wild-type (WT) cells (Fig.  1A) . Treatment with a low concentration of VEGF 164 found normally in physiological angiogenesis (10 ng/ml) resulted in no significant change in adherence for WT, ItgaL Ϫ/Ϫ , or ItgaM Ϫ/Ϫ neutrophils (Fig. 1B) . Conversely, treatment with a high concentration of VEGF 164 (50 ng/ml) stimulated increased WT neutrophil adhesion, whereas ItgaL Ϫ/Ϫ neutrophil adhesion was significantly reduced and ItgaM Ϫ/Ϫ neutrophil adhesion was completely absent (Fig. 1C) . These data show that ItgaM plays a dominant role in regulating neutrophil adhesion to VEGF-A-activated colon microvascular endothelial cells.
RESULTS

Genetic deficiency of ItgaL and ItgaM resulted in decreased neutrophil firm adhesion to VEGF
Genetic deficiency of ItgaM, but not ItgaL, decreases neutrophil rolling on VEGF 164 -stimulated colonic endothelium.
Leukocyte rolling initiates firm adhesion to endothelium, which then allows transmigration into the inflamed tissue. ItgaL/Itgb2 and ItgaM/Itgb2 can modulate this process through interactions with the CAMs ICAM-1 and VCAM-1 to stabilize rolling responses (2, 8, 9, 17) . We next measured the number of rolling WT, ItgaL Ϫ/Ϫ , or ItgaM Ϫ/Ϫ neutrophils in response to TNF-␣ (10 ng/ml, control), low concentration of VEGF 164 (10 ng/ml), and high concentration of VEGF 164 (50 ng/ml). Figure 2A reports that the numbers of slow-rolling WT, ItgaL Ϫ/Ϫ , or ItgaM Ϫ/Ϫ neutrophils increase significantly upon TNF-␣ stimulation of the colonic endothelium. Stimulation with 10 ng/ml VEGF 164 did not significantly alter the rolling of any neutrophil genotype (Fig. 2B) . Conversely, treatment with 50 ng/ml VEGF 164 resulted in a significantly higher number of rolling neutrophils from all genotypes; however, ItgaM Ϫ/Ϫ neutrophils exhibited significantly lower numbers of rolling neutrophils compared with WT and ItgaL Ϫ/Ϫ genotypes (Fig.  2C) . Together, these experiments demonstrate that ItgaM is an important regulator of neutrophil rolling on VEGF 164 -stimulated colon endothelial cells, suggesting that ItgaM is the dominant leukocyte Itgb2 for neutrophil recruitment. 164 -stimulated colonic endothelium. Figure 3A shows that both ItgaL Ϫ/Ϫ and ItgaM Ϫ/Ϫ T cells firmly adhere in a similar manner to TNF-␣-stimulated colon endothelial cells; however, these responses are significantly less than that of WT T cells. Stimulation of the endothelium with 10 ng/ml VEGF 164 caused no deviation from control adhesion levels for WT, ItgaL Ϫ/Ϫ , or ItgaM Ϫ/Ϫ T cells (Fig. 3B) . High-dose VEGF 164 caused increased WT T cell firm adhesion. However, opposite of what we observed with neutrophils, both ItgaL Ϫ/Ϫ -deficient and ItgaM Ϫ/Ϫ -deficient T cells were unable to adhere to colon endothelium treated with 50 ng/ml VEGF 164 (Fig.  3C ). These data show that both ItgaL and ItgaM serve impor- tant roles in mediating CD3 T cell adhesion to VEGF-Aactivated colon endothelial monolayers. 164 stimulated colonic endothelium. We next examined the effects of ItgaL and ItgaM genetic deficiency on T cell rolling responses on VEGF 164 -stimulated colonic endothelium. ItgaL Ϫ/Ϫ T cells showed significantly blunted rolling on TNF-␣-stimulated colon microvascular endothelium; however, TNF-␣ still increased rolling compared with ItgaL Ϫ/Ϫ control (Fig. 4A) . Surprisingly, ItgaM deficiency also decreased T cell rolling on TNF-␣-stimulated colon endothelium (Fig. 4A) . Stimulation of colon endothelium with 10 ng/ml VEGF 164 caused a minimal increase in WT T cell rolling (Fig. 4B) . Figure 4C reports slow rolling of T cells across 50 ng/ml VEGF 164 -treated colon endothelium. WT T cells rolled at significantly higher numbers, whereas ItgaL Ϫ/Ϫ T cells showed a blunted response to VEGF stimulation; however, ItgaL Ϫ/Ϫ rolling was still greater than its respective control. ItgaM Ϫ/Ϫ T cell rolling was increased on VEGF-activated endothelial cells but was again significantly lower than that of WT T cells (Fig.   4C ). These data suggest that both ItgaL and ItgaM are involved in T cell slow rolling with ItgaL serving a dominant role.
Genetic deficiency of ItgaL or ItgaM decreases T cell firm adhesion to VEGF
Loss of ItgaL and ItgaM affected T cell rolling on VEGF
Differential VEGFR activation governs neutrophil and T cell rolling and adhesion. VEGFR1 and R2 are known to play different roles in VEGF-A stimulation. We and others have shown that the major VEGFR2 ligand VEGF 164 plays a pathological role in experimental colitis, whereas VEGF 120 and VEGF 188 , which have a high affinity for VEGFR1, may be involved in wound healing during disease (4, 5, 11, 16, 26) . Having examined how ItgaL and ItgaM regulate leukocyte recruitment in response to VEGF-A, we next examined the role of VEGFR1 and VEGFR2 in regulating VEGF-A-dependent neutrophil or T cell interactions with VEGF 164 -stimulated endothelium. Figure 5A shows that VEGF-A stimulation of colonic endothelium increases neutrophil rolling, which is blocked by VEGFR2 inhibition. Likewise, Fig. 5B illustrates that VEGFR2 inhibition also significantly blunts VEGF 164 -mediated neutrophil firm adhesion. Importantly, inhibition of VEGFR1 did not significantly attenuate neutrophil rolling or firm adhesion. Continuing this line of investigation, we next examined the effect of VEGFR inhibition on VEGF-A-stimulated T cell recruitment. Figure 5C shows that VEGF 164 stimulation of colonic endothelium significantly increases T cell rolling, which is not altered by VEGFR inhibition. Conversely, Fig. 5D shows that inhibition of either VEGFR1 or VEGFR2 significantly inhibits VEGF 164 -mediated T cell firm adhesion. These data reveal an interesting and surprising finding that VEGFRs differentially regulate T cell firm adhesion but do not significantly alter rolling behavior.
DISCUSSION
During chronic inflammatory diseases such as IBD, atherosclerosis, rheumatoid arthritis, and others, angiogenesis is known to contribute to disease pathology (5). Our group and others have recently characterized this pathological angiogenesis in experimental colitis and shown that modulation of the angiogenic response reduces inflammatory pathology (3-6). However, the important molecular mediators and pathways that govern the relationship between inflammation and angiogenesis remain poorly understood. Previous work from our laboratory reported that the loss of CD18 (Itgb2) resulted in decreased neutrophil and T cell adhesion as well as attenuated disease pathology in experimental colitis (4, 13) . Specifically, we reported that high doses of VEGF 164 caused increased neutrophil and T cell firm adhesion to colonic endothelium and that VEGF 164 caused ICAM-1 upregulation (13). Importantly, the loss of CD18 integrin, and thus ItgaL and IgtaM, negated these leukocyte responses (13) . However, it is not known which of the Itgb2s are important for T cell or neutrophil adhesion to VEGF-stimulated colon endothelium. In this present study, we used neutrophils and T cells purified from ItgaL Ϫ/Ϫ and ItgaM Ϫ/Ϫ mice in conjunction with colon endothelial cell monolayers stimulated with VEGF 164 to determine specific integrin adhesion molecule requirements for VEGF 164 -dependent neutrophil and T cell recruitment.
As demonstrated in previous studies, we observed that both ItgaL and ItgaM serve redundant roles in regulating neutrophil firm adhesion to TNF-␣-stimulated colon endothelial cells compared with WT neutrophils (7, 8) . However, we found that genetic deficiency of ItgaL attenuated neutrophil firm adhesion to VEGF-A-treated endothelium, yet ItgaM-deficient neutrophils were completely incapable of firmly adhering to VEGF-A-activated colon endothelium. This differential response between the two Itga mutants suggests that ItgaM plays a more critical role in modulating neutrophil firm adhesion to VEGF-A-activated endothelium that also involves a secondary role for ItgaL. Previous studies have demonstrated functional integrin cooperation as well as outside-in activation of other nonidentical integrins (14) . As such, it is possible that ItgaM may engage in either or both of these responses, which require closer investigation in future studies. Importantly, we believe that the molecular mechanisms behind these results predominantly lie with integrin-dependent firm adhesion responses, as genetic deficiency of ItgaM modestly yet significantly diminished neutrophil rolling on VEGF-A-stimulated endothelium. 5 . Effects of VEGF receptor (VEGFR) inhibition on neutrophil and T cell recruitment to VEGF164-stimulated colonic endothelium. WT neutrophil slow rolling (A) and firm adhesion (B) in response to nonstimulation (control), TNF-␣ (10 ng/ml), VEGF164 (10 ng/ml), VEGF164 (50 ng/ml), VEGF164 (50 ng/ml) with VEGFR1 inhibitor, and VEGF164 (50 ng/ml) with VEGFR2 inhibitor are shown. C and D: WT T cell slow rolling (C) and firm adhesion (D) in response to nonstimulation (control), TNF-␣ (10 ng/ml), VEGF164 (10 ng/ml), VEGF164 (50 ng/ml), VEGF164 (50 ng/ml) with VEGFR1 inhibitor, and VEGF164 (50 ng/ml) with VEGFR2 inhibitor. N ϭ 4 plates, 24 fields for all groups. *P Ͻ 0.05 vs. control, **P Ͻ 0.001 vs. control, ***P Ͻ 0.0001 vs. control, #P Ͻ 0.05 vs. VEGF164 (50 ng/ml).
Future experiments are necessary to better understand specific mechanisms of ItgaM-mediated adhesion to VEGF-A-activated colon endothelial cells.
T cells are a major contributing factor behind chronic inflammatory conditions such as colitis (21, 22, 29) . During disease they are believed to initiate neutrophil infiltration into the colon followed by a larger secondary T cell influx into the colon. We found that the loss of either ItgaL or ItgaM caused a significant reduction in T cell firm adhesion to VEGF-A colon endothelial cells, which also involved decreased rolling behavior in integrin deficiency genotype. It is interesting to see that genetic deficiency of ItgaM diminishes T cell firm adhesion to either TNF-␣-or VEGF-A-activated colon endothelial cells. However, some reports do suggest that ItgaM can contribute to T cell recruitment and adhesion even though it is not typically considered a T cell-associated integrin (15) . Moreover, these data clearly demonstrate that genetic deficiency of ItgaL or ItgaM essentially ablates T cell firm adhesion to VEGF-A-stimulated endothelium, unlike that of TNF-␣-treated endothelium. This finding strongly suggests that VEGF-A-mediated T cell recruitment is largely governed by the Itgb2 protein family vs. members of the Itgb1 family. This is consistent with our previous reports demonstrating that the Itgb2 family predominantly regulates various models of experimental colitis (1, 23, 24) .
The physiological actions of VEGF-A are carried out by the VEGFRs, VEGFR1 and VEGFR2, and the tyrosine kinase receptors have different binding affinities for the various VEGF isoforms. VEGF 120 preferentially binds VEGFR1 as does the cleaved form (active form, VEGF 110 ) of VEGF 188 and VEGF 205 . VEGF 164 preferentially binds VEGFR2, usually linking two VEGFR2s, and can also cobind neurophilin-1-enhancing VEGFR2 signaling. VEGFR2 is indicated as being responsible for the pathological angiogenic responses observed in chronic inflammation, whereas VEGFR1 is thought to produce a "decoy effect" limiting VEGFR2 activity (10) . Here we show that inhibition of VEGFR2 functionally prevents VEGF 164 -stimulated neutrophil rolling and firm adhesion. Our data are the first to show that VEGFR2 is the dominant regulator of neutrophil slow rolling and firm adhesion on colon endothelial cells, which highlights an important molecular target for dual antiangiogenic and anti-inflammatory approaches. Our findings also extend mechanistic understanding by which VEGF-A contributes to inflammation, via VEGF 164 activation of colon endothelial cell VEGFR2, causing increased ItgaM-dependent neutrophil recruitment.
In contrast, inhibition of VEGFR1 or R2 had no effect on T cell rolling behavior but did significantly decrease the numbers of firmly adherent T cells. These data suggest that both VEGFR1 and VEGFR2 activations by VEGF 164 result in mainly ItgaL/ItgaM-dependent T cell recruitment. Together, these data reveal unique differential regulation of T cell recruitment to VEGF-A-activated colon endothelium, indicating that discrete inhibition of different VEGFRs may alter specific immune responses that regulate colitis initiation and progression.
In summary, we have shown here that VEGF 164 activation of colon endothelial cells through VEGFR1 and VEGFR2 differentially increases leukocyte recruitment and that this occurs in an ItgaM-dependent manner for neutrophils and dual ItgaL/ ItgaM manner for T cells. This builds on our earlier report showing that deficiency of Itgb2 reduces leukocyte recruitment to VEGF-A-stimulated colonic endothelium. Importantly, these findings suggest possible new pathophysiological mechanisms of leukocyte involvement in chronic inflammatory settings while clarifying how angiogenic mediators may elicit inflammatory responses that contribute to inflammation during colitis.
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